Mater Dei stock reports BRL 613.63 million in 2Q26 revenue
Published on 10/01/2026 at 05:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Mater Dei stock is anchored by BRL 613.63 million in second-quarter revenue, with net income of BRL 44.25 million and EBITDA of BRL 126.21 million for 2Q26. The results were released on August 12, 2026, as the Brazilian hospital operator continues to balance operating recovery with regulatory obligations.
Revenue and earnings advance
According to Investing.com, quarterly revenue rose 6.73 percent from the prior quarter to BRL 613.63 million, while EBITDA increased 10.36 percent to BRL 126.21 million. The same 2Q26 data show net income at BRL 44.25 million, giving investors a clearer measure of earnings conversion than revenue alone.
The quarterly figures compare with the company’s 2025 revenue of BRL 2.175 billion and net income of BRL 110.51 million, also reported by Investing.com. Because the annual and quarterly figures cover different periods, the key signal is the sequential improvement in 2Q26 rather than a direct annual comparison.
Free float deadline moves out
A separate regulatory development adds a second theme for shareholders. On September 9, 2026, TipRanks reported that B3 extended the deadline for Mater Dei to maintain a free float of at least 15.00 percent from December 31, 2026, to December 31, 2027.
The extension does not directly change revenue, earnings or debt, but it gives the company more time to manage its share structure while preserving its Novo Mercado listing. The same report said the company’s fourth share repurchase program allows purchases of up to 9.3 million ordinary shares through December 1, 2027.
Market value and trading range
Mater Dei had a market value of BRL 1.7 billion as of September 9, 2026. Its B3 share price was BRL 4.98 on that date, with a 52-week range of BRL 4.13 to BRL 6.17, placing the quoted value 20.58 percent above the low and 19.29 percent below the high.
The company’s investor-relations calendar lists the 2Q26 earnings release on August 12, 2026, and the earnings presentation on August 13, 2026, according to Rede Mater Dei. For investors, the next evidence point is whether the 6.73 percent sequential revenue gain and 10.36 percent EBITDA increase can support further margin improvement.
Mater Dei stock at a glance
- Company: Hospital Mater Dei S.A.
- Ticker: MATD3
- Primary exchange: B3
- Market capitalization: BRL 1.7 billion (as of September 9, 2026)
- 52-week range: BRL 4.13-BRL 6.17 (as of September 9, 2026)
- Sector / Industry: Health Care / Healthcare Providers and Services
